Journal of Diabetology (Jan 2020)

The role of hydroxychloroquine in COVID-19: Where do we stand?

  • Ranjit Mohan Anjana,
  • Nadiminty Ganapathi Sastry,
  • Muthu Ramuu,
  • Prasanna Kumar Gupta,
  • Jaggi Shalini,
  • Brijendra Kumar Srivastava,
  • Chaithanya Murthy Kocherlakota,
  • Tata Sameer Nandan,
  • Gangadhara Praveen,
  • Jyotish Nair,
  • Routray Philips,
  • Viswanathan Mohan,
  • Ranjit Unnikrishnan

DOI
https://doi.org/10.4103/JOD.JOD_33_20
Journal volume & issue
Vol. 11, no. 2
pp. 65 – 70

Abstract

Read online

Hydroxychloroquine (HCQ) is a drug, which has long been used in the treatment of malaria, rheumatoid arthritis, systemic lupus erythematosus, and Sjogren’s syndrome. Recently with the COVID-19 pandemic hitting the world, there have been studies suggesting that hydroxychloroquine may be useful both in the prevention and the treatment of COVID-19, although the evidence so far has been conflicting. This article reviews the available evidence for the use of hydroxychloroquine in COVID-19 and also mentions some of the ongoing trials in this field.

Keywords